HCG as tumour marker, Serum - method ( ECLIA )*

The Beta-hCG test is used as a tumor marker to help diagnose, monitor treatment, and detect recurrence of certain cancers, especially testicular, ovarian, and gestational trophoblastic tumors.

• Testicular cancer (non-seminomatous germ cell tumors)
• Ovarian germ cell tumors
• Choriocarcinoma
• Gestational trophoblastic disease (GTD)
• Occasionally: Lung, liver, gastric, and pancreatic cancers

Yes. Elevated Beta-hCG can also be seen in:

• · Pregnancy (normal and ectopic)
• · Recent miscarriage or abortion
• · Certain benign tumors (like hydatidiform mole)

Both.

• · In men, it's mainly used to diagnose and monitor testicular cancer.
• · In women, it's helpful in diagnosing ovarian germ cell tumors or gestational trophoblastic diseases.

A blood sample is collected, usually from a vein. No special preparation is required unless advised by your doctor.

In non-pregnant individuals, high Beta-hCG levels may suggest the presence of certain cancers. Further evaluation with imaging and additional tests is necessary.

The frequency depends on the type and stage of cancer, but it is commonly tested before, during, and after treatment to monitor progress or detect recurrence.

No. Beta-hCG is used alongside other diagnostic tools, including imaging, biopsy, and other tumor markers like AFP or LDH.

• · In non-pregnant adults: typically <5 mIU/mL
• · Levels above this threshold, in the absence of pregnancy, may require further investigation.

• · Individuals with testicular or pelvic masses
• · Women with abnormal bleeding or suspected GTD
• · Patients undergoing cancer treatment or follow-up